Explore more publications!

Press Releases

Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
CWS Hygiene International Selects Go Autonomous to Power Autonomous Commerce in B2B Operations
Go Autonomous Launches Full Support for Agentic Commerce - creating a new frontier in B2B Commerce
ISS extends significant contract with global technology company in North America
Ukraine’s Potential Role in NATO’s Arctic Defense

Ukraine’s Potential Role in NATO’s Arctic Defense

Trends in Solid Bleached Sulfate (SBS) Board Market 2025-35
Global Advanced Wound Care Market to Reach USD 19.32 Billion by 2030 | MarketsandMarkets™
Fruit Snacks Market Size to Worth 48.60 billion by 2035, Fueled by Health, Innovation, and AI-Driven Trends
Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris
Coffee Extract Market Set to Reach USD 2.33 Billion by 2035, Driven by Functional Beverages and AI-Optimized Production
Cochin Shipyard to build next-generation electric TRAnsverse tugs for Svitzer
Vehicle-to-Grid Technology Market Grows Rapidly as EV Adoption and Smart Grid Investments Accelerate Worldwide
CEO Jens-Peter Saul is leaving Ramboll
London Drivers Most Likely to Check Their Phones While Driving
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health
Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
Nanobiotechnology Market to Hit USD 420.2 Billion by 2034, Fueled by 2025 Traffic Growth and Strategic Material & Product Innovations
Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions